CAMBRIDGE, England & SAN DIEGO–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments. Validated at the University of Minnesota (UMN) Genomics Center, this integration delivers enhanced sensitivity for applications including cancer, aging, and neurodegenerative disease with t
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
